Publicado 4 números por año
ISSN Imprimir: 0893-9675
ISSN En Línea: 2162-6448
Indexed in
Modulation of Immune Responses by Histone Deacetylase Inhibitors
SINOPSIS
Recent studies have demonstrated that histone deacetylase (HDAC) inhibitors (HDACi) have potential immunomodulatory activity since they affect the immune surveillance by regulating the production of cytokines, alter the activity and function of macrophages and dendritic cells (DC), regulate the transcription of a variety of immune-stimulating genes, and can modulate the activity of immune effector cells of both the innate and adaptive immune system. Besides their immunostimulatory activity, HDACi can induce growth arrest and cell death, and modulate a subset of cellular functions such as cell motility or differentiation. This makes HDACi interesting therapeutic candidates for the treatment of a variety of human diseases like cancer, autoimmune, and graft versus host diseases. Besides these, HDACs have been shown to be involved in virus replication and pathogenesis, and it was recently shown that HDACi provide therapeutic effects in the treatment of oncogenic virus infections and associated malignancies. This review will further give information about the different families of HDACs and their opponents, the histone acetylases (HATs), about the classes and function of specific HDACi, and their use in the treatment of human diseases.
-
Dörner Thomas, Lipsky Peter E., Beyond pan-B-cell-directed therapy — new avenues and insights into the pathogenesis of SLE, Nature Reviews Rheumatology, 12, 11, 2016. Crossref
-
Sauer M, Schuldner M, Hoffmann N, Cetintas A, Reiners K S, Shatnyeva O, Hallek M, Hansen H P, Gasser S, von Strandmann E P, CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells, Oncogene, 36, 7, 2017. Crossref
-
Hennig Dorle, Imhof Diana, Encapsulation of the HDACi Ex527 into Liposomes and Polymer-Based Particles, in HDAC/HAT Function Assessment and Inhibitor Development, 1510, 2017. Crossref
-
Pasyukova Elena G., Vaiserman Alexander M., HDAC inhibitors: A new promising drug class in anti-aging research, Mechanisms of Ageing and Development, 166, 2017. Crossref
-
Zhang Qing, Dai Yifan, Cai Zhiming, Mou Lisha, HDAC Inhibitors: Novel Immunosuppressants for Allo- and Xeno- Transplantation, ChemistrySelect, 3, 1, 2018. Crossref
-
Robinson Kelsy, Ma Xi, Liu Yulan, Qiao Shiyan, Hou Yongqing, Zhang Guolong, Dietary modulation of endogenous host defense peptide synthesis as an alternative approach to in-feed antibiotics, Animal Nutrition, 4, 2, 2018. Crossref
-
Fecek Ronald J., Raveendran Subhara, Chelvanambi Manoj, Storkus Walter J., Inhibition of HSPs for Enhanced Immunity, in Heat Shock Proteins in the Immune System, 2018. Crossref
-
Deng Zhuo, Wang Jing, Lyu Wentao, Wieneke Xuwen, Matts Robert, Ma Xi, Zhang Guolong, Development of a Cell-Based High-Throughput Screening Assay to Identify Porcine Host Defense Peptide-Inducing Compounds, Journal of Immunology Research, 2018, 2018. Crossref
-
Tabrez Shams, Jabir Nasimudeen R., Khan Mohammad Imran, Khan Mohd Shahnawaz, Shakil Shazi, Siddiqui Ali Nasir, Zaidi Syed Kashif, Ahmed Bakrudeen Ali, Kamal Mohammad Amjad, Association of autoimmunity and cancer: An emphasis on proteolytic enzymes, Seminars in Cancer Biology, 64, 2020. Crossref
-
Luque-Martin Rosario, Van den Bossche Jan, Furze Rebecca C., Neele Annette E., van der Velden Saskia, Gijbels Marion J.J., van Roomen Cindy P.P.A., Bernard Sharon G., de Jonge Wouter J., Rioja Inmaculada, Prinjha Rab K., Lewis Huw D., Mander Palwinder K., de Winther Menno P.J., Targeting Histone Deacetylases in Myeloid Cells Inhibits Their Maturation and Inflammatory Function With Limited Effects on Atherosclerosis, Frontiers in Pharmacology, 10, 2019. Crossref
-
Zhou Liang, Zhang Yu, Meads Mark B., Dai Yun, Ning Yanxia, Hu Xiaoyan, Li Lin, Sharma Kanika, Nkwocha Jewel, Parker Rebecca, Bui Danny, McCarter Jacquelyn, Kramer Lora, Purcell Cullen, Sudalagunta Praneeth R., Canevarolo Rafael R., Coelho Siqueira Silva Maria D., De Avila Gabriel, Alugubelli Raghunandan Reddy, Silva Ariosto S., Kmeiciak Maciej, Ferreira-Gonzalez Andrea, Shain Kenneth H., Grant Steven, IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB– and caspase-8–dependent mechanisms, Blood Advances, 5, 19, 2021. Crossref
-
He Feng, Chou C. James, Scheiner Matthias, Poeta Eleonora, Yuan Chen Natalia, Gunesch Sandra, Hoffmann Matthias, Sotriffer Christoph, Monti Barbara, Maurice Tangui, Decker Michael, Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model, Journal of Medicinal Chemistry, 64, 7, 2021. Crossref
-
Pavel Alisa, del Giudice Giusy, Federico Antonio, Di Lieto Antonio, Kinaret Pia A S, Serra Angela, Greco Dario, Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment, Briefings in Bioinformatics, 22, 2, 2021. Crossref
-
Chu Yuxin, Zhang Cheng, Xie Min, Beta-Hydroxybutyrate, Friend or Foe for Stressed Hearts, Frontiers in Aging, 2, 2021. Crossref
-
Tordera Rosa María, Cortés-Erice María, Role of Histone Deacetylases in Monocyte Function in Health and Chronic Inflammatory Diseases, in Reviews of Physiology, Biochemistry and Pharmacology, 180, 2021. Crossref
-
Xu Jidong, Mao Junyong, Han Xiao, Shi Fushan, Gao Qin, Wang Tingjun, Zhang Zhenning, Shan Ying, Fang Weihuan, Li Xiaoliang, Williams Bryan R. G., Porcine Epidemic Diarrhea Virus Inhibits HDAC1 Expression To Facilitate Its Replication via Binding of Its Nucleocapsid Protein to Host Transcription Factor Sp1, Journal of Virology, 95, 18, 2021. Crossref
-
Sullivan Jessica, Feng Zhihui, Fahey Paul, Agho Kingsley, Hurley Simon, Lim David, Histone deacetylase inhibitor use as a radiosensitizer in solid organ malignancies: a systematic review protocol, JBI Evidence Synthesis, 20, 9, 2022. Crossref
-
Morales Demosthenes, Micheva-Viteva Sofiya, Adikari Samantha, Werner James, Wolinsky Murray, Hong-Geller Elizabeth, Kim Jinwoo, Ojima Iwao, Targeting the Bet-Hedging Strategy with an Inhibitor of Bacterial Efflux Capacity Enhances Antibiotic Efficiency and Ameliorates Bacterial Persistence In Vitro, Microorganisms, 10, 10, 2022. Crossref